This is a routine executive appointment with no immediate financial read-through. Monitor for upcoming clinical data readouts or pipeline updates that may be influenced by Dr. Patni's leadership.
Price Chart
Executive Summary
Septerna appointed Rajiv Patni, M.D., as Chief Medical Officer, effective August 24, 2026. Dr. Patni brings over 25 years of biopharmaceutical experience and a track record of 10 regulatory approvals, which is a positive signal for the company's clinical-stage pipeline execution. This is a routine executive hire for a clinical-stage biotech and does not include any financial data or guidance changes.
Key Facts
- Septerna appointed Rajiv Patni, M.D., as Chief Medical Officer, effective August 24, 2026.
- Dr. Patni has over 25 years of experience and has contributed to 10 regulatory agency approvals or label expansions.
- He most recently served as CEO of Judo Bio and previously as CMO at Global Blood Therapeutics, Portola Pharmaceuticals, and Adamas Pharmaceuticals.
- The filing contains no financial data, guidance, or material business updates.
Financial Impact
No financial impact disclosed in the filing.
Risk Factors
- No financial data or guidance was provided in the filing.
- The appointment does not change the company's near-term cash runway or clinical timelines.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-364210 |
| Document: 0001193125-26-364210-index.html | 0001193125-26-364210 |
| Document: 0001193125-26-364210.txt | 0001193125-26-364210 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 21d ago | Press Release | $38.51 $38.69 | ▲ +0.47% | ▲ +0.69% | $38.27 (−0.62%) |
Sep 3, 2026 28d ago | 3 | $36.75 $39.55 | ▲ +7.62% | ▲ +8.83% | $38.27 (+4.14%) |
Aug 25, 2026 5w ago | 8-K | $41.30 $37.68 | ▼ −8.77% | ▼ −8.23% | $38.27 (−7.34%) |
Aug 14, 2026 6w ago | Insider Cluster | $44.20 $40.52 | ▲ +8.33% | ▲ +7.14% | $38.27 (+13.42%) |
Aug 14, 2026 6w ago | Insider Cluster | $44.20 $40.52 | ▲ +8.33% | ▲ +7.14% | $38.27 (+13.42%) |
Aug 12, 2026 7w ago | 144 | $45.14 $40.79 | ▲ +9.64% | ▲ +7.67% | $38.27 (+15.22%) |
Aug 12, 2026 7w ago | 144 | $45.14 $40.79 | ▲ +9.64% | ▲ +7.67% | $38.27 (+15.22%) |
Aug 10, 2026 7w ago | 8-K | $47.76 $43.80 | ▼ −8.29% | ▼ −7.89% | $38.27 (−19.87%) |
Aug 10, 2026 7w ago | Press Release | $47.76 $43.80 | ▼ −8.29% | ▼ −7.89% | $38.27 (−19.87%) |
Jul 2, 2026 13w ago | Insider Cluster | $34.00 $37.84 | ▲ +11.29% | ▲ +10.36% | $38.27 (+12.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access